Why Steroid-Toxicity Must Be Measured: The Clinical and Economic Case
Patients receiving oral steroids for three to four years carry twice the risk of death compared with steroid-naive control groups. That figure comes from a 2022 population-based study of 223,211 oral ...
Three Phase 3 Trials, Three Decisions to Measure Steroid-Toxicity Directly
Patients on long-term steroids for autoimmune and inflammatory diseases know the damage that these drugs cause. The question for sponsors has long been whether a trial can prove it. In June 2026, ...
.jpg)
Sam User Base Grows 10x in 12 Months
New research presented at EULAR 2026 shows that Steroids and Me (Sam) has grown tenfold since EULAR 2025. With 38,873 users by the end of April 2026, the platform's trajectory reveals the scale of ...
In Conversation With… Peter J. Neumann, ScD
"Nothing in healthcare saves money. It is not quite true, but it is a good adage to keep in mind." Health economics has spent four decades asking whether the trillions spent on US healthcare are ...
Obexelimab Reduces Disease Flares and Steroid-Toxicity in IgG4-RD
An exciting Phase 3 trial has confirmed that obexelimab significantly reduces the risk of disease flare in IgG4-related disease (IgG4-RD) while also delivering measurable reductions in ...
Curious about the true cost of steroid-toxicity?
Download our infographic today
